ReachMD

Frequent fast-food intake and high-temperature cooking methods were linked to higher HbA1c and increased odds of prediabetes in Romanian university students, highlighting dietary patterns affecting glycemic markers. reachmd.com/news/2486325 #prediabetes #nutrition

Review maps links between smartphone exposure and adolescent outcomes in attention, emotional regulation, sleep quality, and social support. Evidence mainly observational; neuroimaging may clarify causal pathways. reachmd.com/news/2486109

“There are no FDA-approved therapies for FSGS.” Dr. Howard Trachtman highlights the urgent need for high-quality clinical trial data in FSGS management: ow.ly/VS2q50YvLXG #FSGS #ClinicalTrials #Nephrology

Severe respiratory viral infections may increase lung cancer risk by creating a tumor-supportive microenvironment, according to UVA-led research combining mouse models and patient data showing higher lung cancer incidence post-COVID hospitalization. reachmd.com/news/2486065

March is National Kidney Month. Hyperkalemia complicates GDMT optimization in patients with CKD and heart failure, yet potassium binder use remains low in clinical practice. This CME activity uses a real-world case to compare patiromer and SZC, review KDIGO guidance, and examine data from REALIZE-K, DIAMOND, and CARE-HK. Hear the full discussion: reachmd.com/u/18428 #NationalKidneyMonth #KidneyMonth #Nephrology #CKD #Hyperkalemia #MedicalEducation

A national survey reveals 53% of Americans would cut everyday expenses to afford non-surgical aesthetic treatments like laser hair removal and injectables, indicating shifting views of these procedures as routine self-care rather than luxury. reachmd.com/news/2486047

Join this upcoming live #AACE2026 symposium where experts will navigate interactive cases to examine the diagnosis and management of acromegaly. Register now: ow.ly/xzvG50YpNpr #Acromegaly #Endocrinology #CM

Does CKD-aP require ongoing treatment? Clinical experience across Europe suggests itch may return after dose reduction or discontinuation. Review long-term management insights this #WorldKidneyDay2026: reachmd.com/u/18441 #NationalKidneyMonth #OurKidneysOurPlanet

As classification of #FSGS evolves, so does discussion around therapeutic application. Drs. Tesar and Lieberman explore maladaptive FSGS in this conversation: ow.ly/iYs250Yej82 #Nephrology

One-year Phase 3 results from the RADIANT-AD trial of rademikibart monotherapy in moderate-to-severe atopic dermatitis will be presented as a Late-Breaking Research oral session at #AAD2026. More on this randomized, placebo-controlled trial: reachmd.com/news/2486000

Maladaptive #FSGS—previously referred to as secondary FSGS—continues to shape clinical thinking. Drs. Tesar and Lieberman share insights on where sparsentan may have clinical relevance: ow.ly/ZOtn50Yek7x #Nephrology

Croatian survey shows dentists have higher diagnostic confidence than pediatricians and GPs for pediatric oral mucosal lesions like hand-foot-and-mouth disease and candidiasis. Diagnostic confidence varies by lesion type. reachmd.com/news/2485963

Narrative review highlights GLP‑1 receptor agonists' potential in addiction treatment, noting no increased risk of psychiatric adverse events, with some studies suggesting mental health benefits. reachmd.com/news/2485950

South Korea continues to set the pace in aesthetic innovation.

Sparsentan worked to reduce proteinuria in FSGS patients in DUPLEX, but didn’t slow GFR loss in a statistically significant way. Hear more from Dr. Howard Trachtman: ow.ly/xjJ150XXjYl #ChronicKidneyDisease #FSGS

A Mayo Clinic study found a single 25 mg dose of Adderall in healthy, Adderall-naïve adults caused acute rises in blood pressure, heart rate, and plasma norepinephrine, indicating sympathetic activation. This may explain acute events with illicit use. reachmd.com/news/2485908

A phase 3 trial in stable HIV patients found that switching to a once-daily bictegravir–lenacapavir single-tablet regimen maintained viral suppression comparable to complex multi-pill regimens without new drug resistance. reachmd.com/news/2485843

March is National Kidney Month. CKD-associated pruritus is common in patients on hemodialysis, yet it is frequently underrecognized. This CME activity reviews validated assessment tools, structured evaluation strategies, and patient-centered management approaches to CKD-aP. Explore the full discussion: reachmd.com/u/18301 #NationalKidneyMonth #OurKidneysOurPlanet #KidneyHealthForAll #KidneyMonth #Nephrology #CKDaP #MedicalEducation

On Rare Disease Day, consider the evolving role of bispecific antibodies in multiple myeloma. Explore data from MajesTEC-3 evaluating teclistamab + daratumumab at first relapse, including durable PFS, deep responses, MRD negativity, and key safety considerations such as CRS and infection risk: reachmd.com/u/18322 #RareDiseaseDay #MultipleMyeloma #Hematology #Oncology

On Rare Disease Day, reflect on the complexity of acute myeloid leukemia (AML). How are molecular profiling and risk stratification shaping treatment decisions? Explore guideline-based sequencing strategies, recent data on menin-directed therapies, adverse event management, and the role of shared decision-making in AML care. Learn more: reachmd.com/u/18319 #RareDiseaseDay #AML #Oncology #CME